In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.
Aurelien Guichard
Advertisement
Articles by Aurelien Guichard
Advertisement
Latest Updated Articles
- Strategic Realignment for a Better Future 1
Published: August 10th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
Direct-to-patient: pharma’s next power move
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
